PHARMORIS pilot-readiness cooperation: evidence, standards and NHS adoption

PHARMORIS is moving from controlled demo evidence toward pilot-readiness for staff-facing medicines workflow and governance use.

I’m looking for project cooperation with people who can help pressure-test the safest and most credible route from prototype evidence to controlled pilot: regulators, standards specialists, NHS innovation teams, clinical-safety leads, IG/data protection experts, AI assurance specialists, medtech operators, funders and evidence-generation partners.

The core question is practical:

What evidence, governance and standards artefacts make medicines workflow software credible enough for serious pilot conversations?

PHARMORIS is designed to help healthcare organisations turn medicines signals into governed ActionCases, evidence packs, human review, blocker tracking, stakeholder acknowledgement, value review and audit trails.

It is not autonomous prescribing, not a prescribing engine and not a replacement for pharmacists, clinicians, finance, procurement or governance.

Cooperation areas I’m especially interested in:

• intended-use wording and safe product boundary
• source provenance and evidence quality
• medicines identity and terminology risks
• AI-assisted drafting with human review
• DCB0129/DCB0160 readiness thinking
• DTAC evidence planning
• IG, DPIA and data minimisation route
• accessibility and usability evidence
• procurement and pilot evaluation design
• metrics that make a controlled medicines workflow pilot credible

This is not a request for endorsement. It is a request for serious, practical conversations that make the pilot route safer, clearer and more adoption-ready.